sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Middle East And Africa Neuromodulation Market Scope And Analysis

  • Report Code : TIPRE00016325
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 113
Buy Now

Middle East and Africa Neuromodulation Market Scope - 2031

Buy Now

Middle East and Africa Neuromodulation Market Report Middle East and Africa Neuromodulation Market Size and Share Middle East and Africa Neuromodulation Market Scope and Analysis

Middle East and Africa Neuromodulation Market Report Scope

Report Attribute Details
Market size in 2019 US$ 1,559.89 Million
Market Size by 2027 US$ 3,518.34 Million
Global CAGR (2020 - 2027) 11.0%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Technology
  • External Neuromodulation
  • Internal Neuromodulation
By Application
  • Chronic Pain Management
  • Failed Back Syndrome
  • Epilepsy
  • Tremor
  • Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson's Disease
  • Obsessive-Compulsive Disorder
  • Migraine
By End User
  • Hospitals
  • Clinics
  • Home Healthcare
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace Inc
  • NeuroSigma Inc
  • NEVRO CORP
  • Synapse Biomedical Inc
  • Soterix Medical Inc
  • Integer Holdings Corporation